Attorney General Marty Jackley says South Dakota will receive $419,000 from a multistate settlement with a drug company.
Pfizer has agreed to pay $35 million to resolve allegations by 42 states that a subsidiary illegally marketed an organ transplant drug for unapproved uses.
Jackley says the misleading claims put consumers' health at risk.
Authorities say Wyeth Pharmaceuticals, which Pfizer bought in 2009, trained sales representatives to encourage doctors to prescribe Rapamune for uses other than preventing rejection of transplanted kidneys.
Rapamune was approved in 1999 for use in kidney transplant patients. It's illegal to promote drugs for uses not cleared by the Food and Drug Administration.
Pfizer says the alleged activity occurred before it acquired Wyeth. The company didn't admit any wrongdoing or liability as part of the settlement.
Most Popular Today
The City's Largest Construction Project Will Impact Thousands
- 2.Retail & Restaurants
Whiffer's Sandwiches Back Open For Business
Costco Citigroup Partnership To Have Impact On Citibank In Sioux Falls
Target Plans $2B In Cost-Cutting Moves
- 5.Your Money Matters
Teeing Off A Business
New Gymnastics Facility Holds First Classes
Citigroup Sells OneMain Financial
Fiat Chrysler Brushes Off Snow, Posts 6 Pct Us Sales Gain
Great Western Bank To Close Two Sioux Falls Branches
- 10.Your Money Matters
Orion Franchise Opening In Dubai